Table 7.
Group performances at follow-ups according to treatment shifts
| Group trends | Excellent | Good | Fair | Poor | P |
|---|---|---|---|---|---|
| Second control signs AZT | 0.0% | 77.1% | 22.9% | 0.0% | P<0.005* |
| Second control signs DOXY | 0.0% | 26.8% | 47.7% | 25.5% | |
| Third control signs AZT | 3.7% | 61.3% | 35.1% | 0.0% | P>0.005 |
| Third control signs DOXY | 0.0% | 60.5% | 39.5% | 0.0% | |
| Third control signs AZT and DOXY | 0.0% | 36.3% | 52.8% | 10.9% | P<0.005* |
| Third control signs DOXY and AZT | 0.0% | 9.9% | 51.3% | 38.8% | |
| Fourth control signs AZT | 8.7% | 56.2% | 28.9% | 6.1% | P<0.005* |
| Fourth control signs DOXY | 0.0% | 15.4% | 72.4% | 12.2% | |
| Fourth control signs AZT and DOXY | 0.0% | 69.6% | 30.4% | 0.0% | P<0.005* |
| Fourth control signs DOXY and AZT | 0.0% | 8.0% | 61.1% | 30.9% |
AZT: Azythromicin; DOXY: Doxycycline; *Statistical significance